Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1 (SLC2A3P1) is a human non-functional DNA sequence classified as a pseudogene and related to the solute carrier family 2 of facilitated glucose transporters, specifically the gene for glucose transporter type 3 (GLUT3). Pseudogenes like SLC2A3P1 resemble known protein-coding genes but lack the ability to produce a functional protein due to disabling mutations or sequence truncations. There are no documented biological roles, drug interactions, or disease associations for SLC2A3P1. This gene should not be confused with the functional glucose transporter genes such as SLC2A3 (GLUT3) or SLC2A6 (GLUT6).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1 (SLC2A3P1).